Last week’s spate of market volatility, the poor July jobs report, and the prospect of Federal Reserve interest rate cuts are together prompting renewed
The GLP-1 (weight-loss drug) boom is continuing to gain steam. As the two leaders in the space, Eli Lilly (LLY) and Novo Nordisk (NVO) stand out as top
Asian shares were mostly higher Thursday after the latest update on U.S. inflation came in almost exactly as economists expected, and data on Japan’s
The fact that inflation is now below 3% for the first time since 2021 is complicating Donald Trump’s ongoing effort to critique Kamala Harris’s economic record. The Consumer Price Index (CPI) dropped below that threshold in July, according to data…
(Bloomberg) -- A rotation into defensive shares coupled with supportive government policies is boosting the appeal of underperforming Chinese health-care
Big investors are bracing for this summer's stock market rout to run into the autumn, fearing a broader wave of selling will follow the turmoil sparked
(Bloomberg) -- Shares of Danish vaccine developer Bavarian Nordic A/S jumped, while other medical product makers also rose, after the World Health
(Bloomberg) -- Equities in Japan and China advanced, following gains on Wall Street, as investors cheered a string of encouraging economic data points
(Bloomberg) -- Moody’s Ratings and S&P Global Ratings may cut Mars Inc.’s credit grades after the candy maker agreed to buy Kellanova for about $36
A bizarrely chilly reception. Shares of Chili’s and Maggiano’s owner Brinker International ( EAT ) were anything but sizzling on Wednesday after its fiscal fourth quarter earnings. The stock tanked 10.7% by the close of trading. Former KFC marketing master…
